Vision-Ease Lens Corporation withdrew its IPO filing today,citing the decision is “consistent with the public interest and protection ofinvestors.” The company originally submitted its IPO paperwork to the SEC on October 13, 2006.
The companyplanned to trade on the Nasdaq Global Market under the symbol “VELS.” The underwritersfor the deal were JPMorgan, William Blair and Company, BMO Capital Markets, andRobert W. Baird and Co.
Vision-Ease designs, manufactures, and distributespolycarbonate prescription lenses globally. They have a patent for LifeRx, a lensthat darkens when exposed to UV rays. With its experience and strategy,Vision-Ease believed its competitive place in the prescription lens marketwould be a good investment for shareholders. They are seeing a new worldthrough those patented lenses and changed their mind.
March 20, 2008